IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ARUN K MUNJAL

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1730150814
CMS profile
169737
Location
SMYRNA, GA

General Payments · PY2018–2024

$9,116.08

  • Reported across 292 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,625.75

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry GA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,625.75 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Axsome Therapeutics, Inc. $286.84 5
Janssen Pharmaceuticals, Inc $273.76 3
Otsuka America Pharmaceutical, Inc. $247.60 7
Supernus Pharmaceuticals, Inc. $176.89 8
Teva Pharmaceuticals USA, Inc. $149.82 3
Noven Pharmaceuticals, Inc. $114.23 1
Corium, Inc. $114.15 11
ITI, Inc. $84.66 5
Neurocrine BioSciences, Inc. $57.41 2
ABBVIE INC. $52.50 2
Noven Therapeutics, LLC $20.71 1
Vanda Pharmaceuticals Inc. $16.47 1
IRONSHORE PHARMACEUTICALS INC. $15.38 1
IDORSIA PHARMACEUTICALS US INC $15.33 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $802.19 27
PY2019 $1,067.44 32
PY2020 $661.80 27
PY2021 $1,790.86 48
PY2022 $1,356.36 54
PY2023 $1,811.68 53
PY2024 $1,625.75 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $33.88 03/07/2024 Food and Beverage Undisputed 01/23/2026 1105082273 CMS
ABBVIE INC. $18.62 04/15/2024 Food and Beverage Undisputed 01/23/2026 1105082275 CMS
Axsome Therapeutics, Inc. $93.89 04/25/2024 Food and Beverage Undisputed 01/23/2026 1148265711 CMS
Axsome Therapeutics, Inc. $20.19 06/11/2024 Food and Beverage Undisputed 01/23/2026 1148265713 CMS
Axsome Therapeutics, Inc. $25.05 09/12/2024 Food and Beverage Undisputed 01/23/2026 1148265715 CMS
Axsome Therapeutics, Inc. $118.54 10/23/2024 Food and Beverage Undisputed 01/23/2026 1148265717 CMS
Axsome Therapeutics, Inc. $29.17 11/27/2024 Food and Beverage Undisputed 01/23/2026 1148265719 CMS
Corium, LLC $21.89 01/04/2024 Food and Beverage Undisputed 01/23/2026 1100091728 CMS
Corium, LLC $5.24 01/18/2024 Food and Beverage Undisputed 01/23/2026 1100132272 CMS
Corium, LLC $5.25 02/26/2024 Food and Beverage Undisputed 01/23/2026 1100132256 CMS
Corium, LLC $19.51 03/04/2024 Food and Beverage Undisputed 01/23/2026 1100099300 CMS
Corium, LLC $2.67 03/04/2024 Food and Beverage Undisputed 01/23/2026 1100135582 CMS
Corium, LLC $6.63 03/28/2024 Food and Beverage Undisputed 01/23/2026 1100129542 CMS
Corium, LLC $5.37 08/12/2024 Food and Beverage Undisputed 01/23/2026 1100145845 CMS
Corium, LLC $18.75 08/29/2024 Food and Beverage Undisputed 01/23/2026 1100174172 CMS
Corium, LLC $3.31 09/23/2024 Food and Beverage Undisputed 01/23/2026 1100142981 CMS
Corium, LLC $5.13 11/18/2024 Food and Beverage Undisputed 01/23/2026 1100218299 CMS
Corium, LLC $20.40 12/05/2024 Food and Beverage Undisputed 01/23/2026 1100218345 CMS
IDORSIA PHARMACEUTICALS US INC $15.33 01/11/2024 Food and Beverage Undisputed 01/23/2026 1146760191 CMS
IRONSHORE PHARMACEUTICALS INC. $15.38 06/20/2024 Food and Beverage Undisputed 01/23/2026 1146274064 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.59 07/25/2024 Food and Beverage Undisputed 01/23/2026 1143283243 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.91 08/22/2024 Food and Beverage Undisputed 01/23/2026 1143283247 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.75 10/03/2024 Food and Beverage Undisputed 01/23/2026 1143283251 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.05 11/07/2024 Food and Beverage Undisputed 01/23/2026 1143283254 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.36 12/12/2024 Food and Beverage Undisputed 01/23/2026 1143283258 CMS
Janssen Pharmaceuticals, Inc $19.04 05/09/2024 Food and Beverage Undisputed 01/23/2026 1077995772 CMS
Janssen Pharmaceuticals, Inc $111.76 08/15/2024 Food and Beverage Undisputed 01/23/2026 1077995764 CMS
Janssen Pharmaceuticals, Inc $142.96 12/19/2024 Food and Beverage Undisputed 01/23/2026 1077995852 CMS
Neurocrine Biosciences, Inc. $23.09 06/13/2024 Food and Beverage Undisputed 01/23/2026 1150846235 CMS
Neurocrine Biosciences, Inc. $34.32 11/12/2024 Food and Beverage Undisputed 01/23/2026 1150819654 CMS
Noven Pharmaceuticals, Inc. $114.23 07/18/2024 Food and Beverage Undisputed 01/23/2026 1084816564 CMS
Noven Therapeutics, LLC $20.71 03/15/2024 Food and Beverage Undisputed 01/23/2026 1084818586 CMS
Otsuka America Pharmaceutical, Inc. $124.50 02/22/2024 Food and Beverage Undisputed 01/23/2026 1118947269 CMS
Otsuka America Pharmaceutical, Inc. $19.06 03/21/2024 Food and Beverage Undisputed 01/23/2026 1118947271 CMS
Otsuka America Pharmaceutical, Inc. $16.88 08/01/2024 Food and Beverage Undisputed 01/23/2026 1118947273 CMS
Otsuka America Pharmaceutical, Inc. $18.82 09/17/2024 Food and Beverage Undisputed 01/23/2026 1118947275 CMS
Otsuka America Pharmaceutical, Inc. $27.51 10/24/2024 Food and Beverage Undisputed 01/23/2026 1118947277 CMS
Otsuka America Pharmaceutical, Inc. $24.22 11/21/2024 Food and Beverage Undisputed 01/23/2026 1118947279 CMS
Otsuka America Pharmaceutical, Inc. $16.61 12/16/2024 Food and Beverage Undisputed 01/23/2026 1118947281 CMS
Supernus Pharmaceuticals, Inc. $43.30 02/01/2024 Food and Beverage Undisputed 01/23/2026 1147847026 CMS
Supernus Pharmaceuticals, Inc. $21.27 02/29/2024 Food and Beverage Undisputed 01/23/2026 1147847024 CMS
Supernus Pharmaceuticals, Inc. $17.11 05/06/2024 Food and Beverage Undisputed 01/23/2026 1147790481 CMS
Supernus Pharmaceuticals, Inc. $28.50 06/04/2024 Food and Beverage Undisputed 01/23/2026 1147790494 CMS
Supernus Pharmaceuticals, Inc. $17.62 07/06/2024 Food and Beverage Undisputed 01/23/2026 1147790485 CMS
Supernus Pharmaceuticals, Inc. $14.51 08/15/2024 Food and Beverage Undisputed 01/23/2026 1147847022 CMS
Supernus Pharmaceuticals, Inc. $14.50 11/14/2024 Food and Beverage Undisputed 01/23/2026 1147790476 CMS
Supernus Pharmaceuticals, Inc. $20.08 12/25/2024 Food and Beverage Undisputed 01/23/2026 1147790490 CMS
Teva Pharmaceuticals USA, Inc. $20.88 01/19/2024 Food and Beverage Undisputed 01/23/2026 1151514887 CMS
Teva Pharmaceuticals USA, Inc. $18.26 03/28/2024 Food and Beverage Undisputed 01/23/2026 1151514939 CMS
Teva Pharmaceuticals USA, Inc. $110.68 06/20/2024 Food and Beverage Undisputed 01/23/2026 1151515011 CMS
Vanda Pharmaceuticals Inc. $16.47 09/05/2024 Food and Beverage Undisputed 01/23/2026 1133913784 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.